Skip to main content
Top

Open Access 06-07-2024 | Diabetic Retinopathy | COMMENTARY

OCTA: Essential or Gimmick?

Authors: Siddharth Gandhi, Niveditha Pattathil, Netan Choudhry

Published in: Ophthalmology and Therapy

Login to get access

Abstract

This commentary article delves into the transformative role of optical coherence tomography angiography (OCTA) in diagnosing and managing a wide array of eye conditions, including diabetic retinopathy, age-related macular degeneration, retinal vein occlusions, and white dot syndromes. Developed in 2005, OCTA has emerged as a non-invasive, high-resolution imaging technique that offers advantages over traditional fluorescein angiography (FA), providing quicker and safer monitoring of ocular conditions with similar diagnostic accuracy. In diabetic retinopathy, OCTA has been instrumental in early identification of retinal changes, offering quantifiable metrics including perfused capillary density (PCD) for assessing vascular alterations. For age-related macular degeneration (AMD), OCTA has deepened our understanding of non-exudative neovascular AMD, allowing for more effective monitoring and potential earlier initiation of treatment. In cases of retinal vein occlusions, OCTA can reveal specific microvascular features and allow for depth-resolved measurements of the foveal avascular zone, providing significant prognostic implications. OCTA has also been invaluable in studying rare white dot syndromes, enabling nuanced differentiation between conditions that often present similarly. Emerging research also suggests that OCTA can have potential utility in neurodegenerative diseases like Alzheimer’s, where retinal vascular patterns could offer diagnostic insights. While OCTA is revolutionizing ophthalmic care, further clinical trials and standardization are needed for its broader adoption into clinical practice.
Literature
2.
go back to reference Matsunaga D, Yi J, Puliafito CA, Kashani AH. OCT angiography in healthy human subjects. Ophthalmic Surg Lasers Imaging Retina. 2014;45(6):510–5.CrossRefPubMed Matsunaga D, Yi J, Puliafito CA, Kashani AH. OCT angiography in healthy human subjects. Ophthalmic Surg Lasers Imaging Retina. 2014;45(6):510–5.CrossRefPubMed
3.
go back to reference Borrelli E, Sarraf D, Freund KB, Sadda SR. OCT angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res. 2018;67:30–55.CrossRefPubMed Borrelli E, Sarraf D, Freund KB, Sadda SR. OCT angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res. 2018;67:30–55.CrossRefPubMed
4.
go back to reference Kwiterovich KA, Maguire MG, Murphy RP, et al. Frequency of adverse systemic reactions after fluorescein angiography: results of a prospective study. Ophthalmology. 1991;98(7):1139–42.CrossRefPubMed Kwiterovich KA, Maguire MG, Murphy RP, et al. Frequency of adverse systemic reactions after fluorescein angiography: results of a prospective study. Ophthalmology. 1991;98(7):1139–42.CrossRefPubMed
5.
go back to reference Rabiolo A, Gelormini F, Marchese A, et al. Macular perfusion parameters in different angiocube sizes: does the size matter in quantitative optical coherence tomography angiography? Investig Ophthalmol Vis Sci. 2018;59(1):231–7.CrossRef Rabiolo A, Gelormini F, Marchese A, et al. Macular perfusion parameters in different angiocube sizes: does the size matter in quantitative optical coherence tomography angiography? Investig Ophthalmol Vis Sci. 2018;59(1):231–7.CrossRef
6.
go back to reference Greig EC, Duker JS, Waheed NK. A practical guide to optical coherence tomography angiography interpretation. Int J Retina Vitreous. 2020;6(1):1–17.CrossRef Greig EC, Duker JS, Waheed NK. A practical guide to optical coherence tomography angiography interpretation. Int J Retina Vitreous. 2020;6(1):1–17.CrossRef
10.
go back to reference Choi W, Waheed NK, Moult EM, et al. Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina. 2017;37(1):11–21.CrossRefPubMedPubMedCentral Choi W, Waheed NK, Moult EM, et al. Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina. 2017;37(1):11–21.CrossRefPubMedPubMedCentral
11.
go back to reference Alam M, Zhang Y, Lim JI, Chan RVP, Yang M, Yao X. Quantitative OCT angiography features for objective classification and staging of diabetic retinopathy. Retina (Philadelphia, Pa). 2020;40:322–32.CrossRefPubMed Alam M, Zhang Y, Lim JI, Chan RVP, Yang M, Yao X. Quantitative OCT angiography features for objective classification and staging of diabetic retinopathy. Retina (Philadelphia, Pa). 2020;40:322–32.CrossRefPubMed
12.
go back to reference Rodrigues TM, Marques JP, Soares M, et al. Macular OCT-angiography parameters to predict the clinical stage of nonproliferative diabetic retinopathy: an exploratory analysis. Eye. 2019;33(8):1240–7.CrossRefPubMedPubMedCentral Rodrigues TM, Marques JP, Soares M, et al. Macular OCT-angiography parameters to predict the clinical stage of nonproliferative diabetic retinopathy: an exploratory analysis. Eye. 2019;33(8):1240–7.CrossRefPubMedPubMedCentral
13.
go back to reference Samara WA, Shahlaee A, Adam MK, et al. Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity. Ophthalmology. 2017;124(2):235–44.CrossRefPubMed Samara WA, Shahlaee A, Adam MK, et al. Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity. Ophthalmology. 2017;124(2):235–44.CrossRefPubMed
21.
go back to reference Shaimov TB, Panova IE, Shaimov RB, Shaimova VA, Shaimova TA, Fomin AV. Optical coherence tomography angiography in the diagnosis of neovascular age-related macular degeneration. Vestn oftalmol. 2015;131(5):4–13.CrossRefPubMed Shaimov TB, Panova IE, Shaimov RB, Shaimova VA, Shaimova TA, Fomin AV. Optical coherence tomography angiography in the diagnosis of neovascular age-related macular degeneration. Vestn oftalmol. 2015;131(5):4–13.CrossRefPubMed
22.
go back to reference Usman M, Iqbal K, Ali MH, Nafees K. Features and diagnostic accuracy of optical coherence tomography angiography in neovascular age-related macular degeneration. Cureus. 2019;11(12):e6485. Usman M, Iqbal K, Ali MH, Nafees K. Features and diagnostic accuracy of optical coherence tomography angiography in neovascular age-related macular degeneration. Cureus. 2019;11(12):e6485.
23.
go back to reference Tombolini B, Crincoli E, Sacconi R, et al. Optical coherence tomography angiography: a 2023 focused update on age-related macular degeneration. Ophthalmol Ther. 2024;13:449–67.CrossRefPubMedPubMedCentral Tombolini B, Crincoli E, Sacconi R, et al. Optical coherence tomography angiography: a 2023 focused update on age-related macular degeneration. Ophthalmol Ther. 2024;13:449–67.CrossRefPubMedPubMedCentral
32.
go back to reference Dingerkus VLS, Munk MR, Brinkmann MP, et al. Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis. J Ophthalmic Inflamm Infect. 2019;9:10.CrossRefPubMedPubMedCentral Dingerkus VLS, Munk MR, Brinkmann MP, et al. Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis. J Ophthalmic Inflamm Infect. 2019;9:10.CrossRefPubMedPubMedCentral
40.
go back to reference Asanad S, Mohammed I, Sadun AA, Saeedi OJ. OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye-brain interface. Ther Adv Ophthalmol. 2020;12:2515841420950508.PubMedPubMedCentral Asanad S, Mohammed I, Sadun AA, Saeedi OJ. OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye-brain interface. Ther Adv Ophthalmol. 2020;12:2515841420950508.PubMedPubMedCentral
41.
go back to reference Rocholz R, Corvi F, Weichsel J, Schmidt S, Staurenghi G. OCT angiography (OCTA) in retinal diagnostics. In: Bille JF, editor. High resolution imaging in microscopy and ophthalmology: new frontiers in biomedical optics. Cham (CH): Springer; 2019; pp 135–160. Rocholz R, Corvi F, Weichsel J, Schmidt S, Staurenghi G. OCT angiography (OCTA) in retinal diagnostics. In: Bille JF, editor. High resolution imaging in microscopy and ophthalmology: new frontiers in biomedical optics. Cham (CH): Springer; 2019; pp 135–160.
42.
go back to reference Baumann B, Merkle CW, Leitgeb RA, et al. Signal averaging improves signal-to-noise in OCT images: but which approach works best, and when? Biomed Opt Express. 2019;10(11):5755–75.CrossRefPubMedPubMedCentral Baumann B, Merkle CW, Leitgeb RA, et al. Signal averaging improves signal-to-noise in OCT images: but which approach works best, and when? Biomed Opt Express. 2019;10(11):5755–75.CrossRefPubMedPubMedCentral
43.
go back to reference Szkulmowski M, Wojtkowski M. Averaging techniques for OCT imaging. Opt Express. 2013;21(8):9757–73.CrossRefPubMed Szkulmowski M, Wojtkowski M. Averaging techniques for OCT imaging. Opt Express. 2013;21(8):9757–73.CrossRefPubMed
Metadata
Title
OCTA: Essential or Gimmick?
Authors
Siddharth Gandhi
Niveditha Pattathil
Netan Choudhry
Publication date
06-07-2024
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-024-00985-0
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare